secwatch / observer
8-K filed November 24, 2023, 6:59 PM ET ticker VANI CIK 0001266806
leadership confidence high sentiment neutral materiality 0.50

Vivani Medical terminates named executive officer Scott Dunbar in subsidiary workforce reduction

Vivani Medical, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Scott Dunbar

Named Executive Officer
VANI · Vivani Medical, Inc.
Effective
2023-11-20
Filed
November 24, 2023, 6:59 PM ET
the Company terminated without cause the employment of Scott Dunbar, a named executive officer in the Company’s 2023 proxy statement and former Acting Chief Executive Officer of the Company’s predecessor, Second Sight Medical Products, Inc., effective as of November 20, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott Dunbar departed as Named Executive Officer at Vivani Medical, Inc..

Action
terminated without cause
Role
Named Executive Officer
Exact text from the filing
the Company terminated without cause the employment of Scott Dunbar, a named executive officer in the Company’s 2023 proxy statement and former Acting Chief Executive Officer of the Company’s predecessor, Second Sight Medical Products, Inc., effective as of November 20, 2023
View on SEC.gov

Vivani Medical, Inc. filing history →

Source: SEC EDGAR
accession 0001753926-23-001534
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.